Streamex Corp

Streamex Corp (STEX) Stock Analysis

$0.772

-0.052 (-6.70%)At close

Loading chart…
High
0.830
Open
0.827
VWAP
0.78
Vol
672.25K
Mkt Cap
Low
0.743
Amount
525.50K
EV/EBITDA, TTM
-0.09

Streamex Corp., formerly BioSig Technologies, Inc., is a real world asset (RWA) tokenization company. The Company with institutional grade infrastructure brings the gold and commodities market on chain, enabled by a gold denominated treasury and tokenization technology powering the modern commodities market. The Company is a wholly owned subsidiary of BioSig Technologies, Inc.

AI analysis of Streamex Corp (STEX)

hold

Streamex Corp (STEX) is not a good buy right now due to its significant financial challenges, including a current price of $0.7718 and a staggering year-to-date change of -75.18%. The company reported a net loss of $14.6 million in Q2 2026, indicating ongoing financial struggles, despite a recent share buyback program aimed at boosting investor confidence. The RSI of 43.972 suggests the stock is nearing oversold territory, but the overall negative trend and high volatility (implied volatility at 154.51) pose substantial risks.

Valuation Metrics

The current forward P/E ratio for Streamex Corp (STEX) is 0.00, compared to its 5-year average forward P/E of -36.97.

Forward P/E

Strongly Overvalued
5Y Average P/E
-36.97
Current P/E
0.00
Overvalued
-30.16
Undervalued
-43.78

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-10.92
Current EV/EBITDA
-0.09
Overvalued
0.70
Undervalued
-22.55

Forward P/S

Fair
5Y Average P/S
6.34
Current P/S
9.42
Overvalued
14.66
Undervalued
-1.98

Events Timeline

2026-07-21 (ET)

09:30:00

Streamex Launches GLDY Class B Shares Custodied by Inspira Financial

2026-07-07 (ET)

08:00:00

Streamex Authorizes Repurchase of 10 Million Shares

2026-06-29 (ET)

09:30:00

Streamex Partners with Siebert Financial and tZERO to Launch GLDY

2026-06-25 (ET)

09:01:00

Angion Biomedica Borrow Rate Increases to 183.97%

2026-05-29 (ET)

09:00:00

Liquid Option Names See Borrow Rate Increases

News

STEX FAQ — answered by Alphio AI

Streamex Corp., formerly BioSig Technologies, Inc., is a real world asset (RWA) tokenization company. The Company with institutional grade infrastructure brings the gold and commodities market on chain, enabled by a gold denominated treasury and tokenization technology powering the modern commodities market. The Company is a wholly owned subsidiary of BioSig Technologies, Inc. It operates in the Financials sector.

Streamex Corp (STEX) is not a good buy right now due to its significant financial challenges, including a current price of $0.7718 and a staggering year-to-date change of -75.18%. The company reported a net loss of $14.6 million in Q2 2026, indicating ongoing financial struggles, despite a recent share buyback program aimed at boosting investor confidence. The RSI of 43.972 suggests the stock is nearing oversold territory, but the overall negative trend and high volatility (implied volatility at 154.51) pose substantial risks.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started